Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 32,692 |
|
|||||
| News | - | ||||||
| Day High | 3.20 | Low High |
|||||
| Day Low | 3.05 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Anixa Biosciences Inc | ANIX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.02 | 0.65% | 3.12 | 15:05:24 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.10 | 3.05 | 3.20 | 3.12 | 3.10 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 384 | 32,692 | US$ 3.11 | US$ 101,617 | - | 2.75 - 5.13 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:14:51 | 1 | US$ 3.09 | USD |
Anixa Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 99.53M | 31.90M | - | 210k | -9.81M | -0.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Anixa Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANIX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.23 | 3.2499 | 3.03 | 3.13 | 71,918 | -0.11 | -3.41% |
| 1 Month | 3.68 | 3.70 | 3.03 | 3.22 | 81,005 | -0.56 | -15.22% |
| 3 Months | 4.45 | 4.70 | 3.01 | 3.71 | 117,604 | -1.33 | -29.89% |
| 6 Months | 3.26 | 5.13 | 2.75 | 3.90 | 150,637 | -0.14 | -4.29% |
| 1 Year | 4.70 | 5.13 | 2.75 | 3.79 | 113,150 | -1.58 | -33.62% |
| 3 Years | 3.83 | 6.45 | 2.30 | 4.09 | 121,257 | -0.71 | -18.54% |
| 5 Years | 4.14 | 8.09 | 1.33 | 3.81 | 189,247 | -1.02 | -24.64% |
Anixa Biosciences Description
| Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing the body's immune system in the fight against cancer. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for early detection of solid tumours which is based on the body's immune response to the presence of a malignancy. The company is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs that genetically engineer patient's own immune cells to fight cancer. |
